In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...